A PHARMACOVIGILANCE STUDY TO ASSESS THE EFFECT OF ADVERSE DRUG REACTION ON PEDIATRIC HEALTH
DOI:
https://doi.org/10.22159/ajpcr.2025v18i9.55392Keywords:
Pharmacovigilance, The World Health Organization, Adverse drug reactions, Antimicrobial drugs, Causative agentsAbstract
Objective: This study investigated the incidence, demographic and clinical patterns, causative agents, causality, and severity of adverse drug reactions (ADRs) in children.
Methods: This study employed a retrospective observational design to investigate ADRs in pediatric patients in the pediatric, ear, nose, and throat, and dermatology departments. ADRs were identified through reports from doctors and nurses, which were based on patient complaints. According to the Institutional Review Board committee’s statement, no ethical committee approval number was required for this study, as it involved only the assessment of symptoms in pediatric patients without any therapeutic interventions. The study was conducted at Chettinad Medical College and Research Institute from March 2011 to February 2012. During this period, 1788 inpatients were monitored for ADRs using a standardized reporting form. The likelihood of ADRs was evaluated using a probability scale, and reactions were classified according to World Health Organization criteria.
Results: The study found an ADR incidence rate of 0.73% among 1788 children. ADRs were more common in children aged 6–10 years (61.5%) and males (61.5%). Antimicrobial drugs were the leading cause of ADRs, responsible for 61.5% of cases. The causality assessment showed that 53.84% of ADRs were possible, 23.07% were probable, 7.69% were certain, and 15.38% were conditional. The majority of ADRs (85%) were mild, while 15% were moderate, and none were severe.
Conclusion: These findings highlight the importance of monitoring ADRs in children to ensure patient safety and promote safe medication use.
Downloads
References
1. Hamid AA, Rahim R, Teo SP. Pharmacovigilance and its importance for primary health care professionals. Korean J Fam Med. 2022;43(5):290-5. doi: 10.4082/kjfm.21.0193, PMID 36168900
2. Patsuree A, Krska J, Jarernsiripornkul N. Experiences relating to adverse drug reactions in the community: A cross-sectional survey among patients and the general public in Thailand. Expert Opin Drug Saf. 2016;15(3):287-95. doi: 10.1517/14740338.2016.1135127, PMID 26750422
3. Shamna M, Dilip C, Ajmal M, Linu Mohan PL, Shinu C, Jafer CP, et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharm J. 2014;22(4):303-8. doi: 10.1016/j. jsps.2013.06.004, PMID 25161373
4. Parthasarthi G, Hansen KN, Nahata M. Medication error and adverse drugs events. In: A Textbook of Clinical Pharmacy Practice. 2nd ed., Ch. 28. Telangana: Orient Blackswan Private Limited; 2012. p. 486-506.
5. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/ out-patients: A systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52(1):77-83. doi: 10.1046/j.0306- 5251.2001.01407.x, PMID 11453893
6. Clavenna A, Bonati M. Adverse drug reactions in childhood: A review of prospective studies and safety alerts. Arch Dis Child. 2009;94(9):724-8. doi: 10.1136/adc.2008.154377, PMID 19531524
7. Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13-20. doi: 10.1080/21556660.2019.1566137, PMID 30729064
8. Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: A qualitative review of empirical studies. Br J Clin Pharmacol. 2010;70(4):481-91. doi: 10.1111/j.1365- 2125.2010.03682.x, PMID 20840440
9. Gallo M, Clavenna A, Bonati M, Siani P, Irpino A, Rossi F, et al. Active surveillance of adverse drug reactions in children in five Italian paediatric wards. Open J Pediatr. 2012;2(2):111-7. doi: 10.4236/ ojped.2012.22019
10. Li H, Guo XJ, Ye XF, Jiang H, Du WM, Xu JF, et al. Adverse drug reactions of spontaneous reports in Shanghai pediatric population. PLoS One. 2014 Feb 24;9(2):e89829. doi: 10.1371/journal.pone.0089829, PMID 24587066
11. Digra KK, Pandita A, Saini GS, Bharti R. Pattern of adverse drug reactions in children attending the department of pediatrics in a tertiary care center: A prospective observational study. Clin Med Insights Pediatr. 2015 Aug 11;9:73-8. doi: 10.4137/CMPed.S29493, PMID 26309424
12. Kurma VR, Manchu T, Amancharla MK, Manchu K, Kandula PK. Pattern of adverse drug reactions in paediatric patients reported to adverse drug reaction monitoring centre in a tertiary care hospital. Int J Contemp Pediatr. 2019;6(4):1557-62. doi: 10.18203/2349-3291. ijcp2019275413. Khan Z, Karataş Y, Kıroğlu O. Evaluation of adverse drug reactions in paediatric patients: A retrospective study in Turkish hospital. Front Pharmacol. 2021;12:786182. doi: 10.3389/fphar.2021.786182, PMID 34867419
14. Priyadharsini R, Surendiran A, Adithan C, Sreenivasan S, Sahoo FK. A study of adverse drug reactions in pediatric patients. J Pharmacol Pharmacother. 2011;2(4):277-80. doi: 10.4103/0976-500X.85957, PMID 22025857
15. Dash M, Jena M, Mishra S, Panda M, Patro N. Monitoring of adverse drug reactions in pediatric department of a tertiary care teaching hospital: A hospital based observational study. Int J Pharm Res All Sci. 2015;4(4):69-76.
16. Valder BK, Neelamma P, Nalini GK, Sahana GN. A study to assess, monitor, and reporting of adverse drug reactions in a tertiary care teaching hospital: HIMS, HASSAN. Asian J Pharm Clin Res. 2023 Jul;16(7):201-3. doi: 10.22159/ajpcr.2023.v16i7.46654
17. Kharat A, Mishra PS, Shinde M, Patel A, Vignan N. Pharmacovigilance in practice: Assessing adverse drug reactions in tertiary Care Hospital Central India. Int J Pharm Pharm Sci. 2025 Feb;17(2):40-6. doi: 10.22159/ijpps.2025v17i2.52982
18. Chandrabhan, Jain P, Jain S. Adverse drug reaction monitoring study in hospitalized patients: Support for pharmacovigilance at a tertiary care hospital. Int J Basic Clin Pharmacol. 2021 Mar;10(3):261-5. doi: 10.18203/2319-2003.ijbcp20210554
19. Jiang, H., Lin, Y., Ren, W., Fang, Z., Liu, Y., Tan, X., et al. Adverse drug reactions and correlations with drug-drug interactions: A retrospective study of reports from 2011 to 2020. Front Pharmacol. 2022;13:923939. doi: 10.3389/fphar.2022.923939, PMID 36133826
20. Deepthi Rani, B. Pharmacovigilance and paediatric drug safety: A comprehensive analysis of adverse drug reactions in children. Int J Acad Med Pharm. 2024;6(3):6-10. doi: 10.47009/jamp.2024.6.3.2
21. James J. A prospective study of adverse drug reactions in A tertiary care hospital in South India. Asian J Pharm Clin Res. 2020;13(1):89-92. doi: 10.22159/ajpcr.2020.v13i1.36028
Published
How to Cite
Issue
Section
Copyright (c) 2025 Subbulakshmi
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
